Get smarter. Succeed faster. Join peers, mentors and colleagues across life science, healthcare and business.

Homepage 345 Pas Video

Be part of Cure

When he was a little boy, Collins “Collogh” Oghor lost his aunt to kidney failure, and now, having earned an MD, MBA, and MPH, he has developed an AI solution to help healthcare providers battle this devastating — and preventable — disease.

Cure Xchange Challenge Finalist Collogh Cares logo

Collogh Cares Logo

Spotlight On: Collogh Cares Co-founder Collins Oghor, MD, MBA, MPH

Grant Mitchell, MD, MBA, and his co-founder are on a mission to use AI to match drugs already on the market with diseases that currently have no cure.  

Spotlight On_Grant_Mitchell_Image

Spotlight On: Grant Mitchell, MD, MBA, CEO and Co-founder of Every Cure

With her co-founder Professor Richard Braatz, PhD, of MIT, Irene Rombel, PhD, MBA, aims to make innovative cell and gene therapies more accessible for people living with devastating rare diseases by overcoming the manufacturing dilemmas plaguing these treatments.

Cure Xchange Challenge Finalist BioCurie logo

BioCurie Logo

Spotlight On: Irene Rombel, PhD, MBA, Co-founder, BioCurie

Driven to help people in marginalized communities get the healthcare they deserve, Jonathan Govette and his co-founders developed an AI solution for identifying people at high risk for lung cancer, so they can get treated early — saving both money and lives.

Cure Xchange Challenge Finalist Oatmeal Health logo

Oatmeal Health Logo

Spotlight On: Oatmeal Health Co-founder Jonathan Govette

As a young radiologist in Casablanca, Morocco, Saad Slimani, MD, MS, noticed an opportunity to use AI to provide all pregnant women, regardless of socioeconomic status, with access to a simple procedure that could save their lives as well as the lives of their babies.

Cure Xchange Challenge Finalist Deepecho logo

Deepecho Logo

Spotlight On: Saad Slimani, MD, MS,  Co-founder of Deepecho

Spotlight

Orange

Sign up for our newsletter to get exclusive news, ideas, and insights directly to your inbox.

Newsletter Sign-Up Call-to-Action Image Mobile

Join the Cure Community

Regular

Facilities

Amenities

Cure Membership

Cure Awards

Cure Conversations

 Insights

CAMPUS & RESIDENCY-PAGE_GRID_ITEM-News releases image

Cure News

Explore Cure’s Collaboration Residency

Advancium Health Network is a volunteer-driven, charitable organization mission-focused on advancing human equity and accelerating innovation to improve health for people globally.

Advancium Health Network logo Cure Collaboration Residency

Advancium Health Network

Apertura is widening the aperture of gene therapy opportunities for treating debilitating diseases. By simultaneously designing AAV capsids, regulatory elements, and payloads, we are working to overcome current limitations in gene delivery and expression. 

Lab research image Cure resident Apertura

Apertura Gene Therapy logo Cure Collaboration Residency

Apertura

Ascertain, a healthcare technology company empowering care teams with AI, helps health systems, payers, and independent provider groups streamline operations and reduce administrative burden. Customers can either deploy Ascertain Automate, an enterprise software platform that uses agentic AI to automate high-volume administrative workflows, or engage Ascertain’s tech-enabled services, outsourcing entire workflows to Ascertain’s team, which operates the software on their behalf. From prior authorization and eligibility checks to discharge planning and patient scheduling, Ascertain’s AI agents navigate complex systems, interpret unstructured data, and integrate across fragmented platforms - enabling faster throughput, lower costs, and more time for patient care.

Ascertain

Buckle Therapeutics is transforming how people access and administer medications by delivering them directly through the cheek — fast, simple, and needle-free. Our platform is designed to support individuals across a wide range of conditions where traditional delivery methods may be impractical, inaccessible, or unwanted.

Buckle Therapeutics

CobiCure MedTech is a non-profit pediatric organization and part of the Advancium Health Network, focused on reimagining pediatric medical technology through its strategic ecosystem, critical resources, leadership and funding—ensuring that return on investment is not a determinant for bringing life-changing pediatric medical technologies to children. 

Pediatric care image for Cure resident CobiCure Medical Technologies

CobiCure MedTech

ConcertoCare is a tech-enabled, value-based provider of at-home, comprehensive care for seniors and other adults with unmet health and social needs.

Website hero image Cure resident Concerto Care

Concerto Care logo Cure Collaboration Residency

Concerto Care

Deerfield Catalyst is a premier medtech incubator founded to develop transformational medtech solutions that improve outcomes and streamline patient care.

Deerfield Catalyst Cure resident website image

Deerfield Catalyst logo Cure Collaboration Residency

Deerfield Catalyst

Deerfield works across the healthcare ecosystem, connecting people, capital, ideas, and technology in new, and often unexpected ways.

Launched in 1994, Deerfield is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care. As of December 2023, the firm manages more than $14.6 billion in assets.

Providing value beyond capital, Deerfield generally maintains a combined portfolio of more than 200 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Collaboration, intellectual curiosity and pragmatism drive Deerfield’s approach. With its holistic view, Deerfield tailors flexible financing options designed to meet the needs of entrepreneurs and corporate partners.

Deerfield Management Company

Entrypoint is an investment management firm that fuses fundamental and systematic investment styles, integrating deep domain expertise with quantitative techniques. 

Cure resident EntryPoint Capital hero image

EntryPoint Capital logo Cure Collaboration Residency

EntryPoint Capital

Chronic inflammatory diseases are the most significant cause of death in the world, and those who live with them have a reduced quality of life. Evommune’s goal is to drive meaningful advances for patients by targeting inflammation at the source, to not only address symptoms but avoid disease progression.

Evommune logo Cure Collaboration Residency

Evommune

Helaina's precision fermentation platform replicates functional proteins found in the human body, making them available as new nutrients.

Helaina logo Cure Collaboration Residency

Helaina

Hop Labs is a research and development lab focused on building state-of-the-art and scalable machine-learning solutions. 

Hop Labs

Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. 

Insilico logo Cure Collaboration Residency

Insilico Medicine

A clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.

Cure resident Lexeo Therapeutics website hero image

LEXEO Therapeutics logo Cure Collaboration Residency

Lexeo Therapeutics

Metallomix Inc. is a clinical stage biotech company targeting isotopic dysfunction – a previously unrecognized driver of cancer and diseases of aging including neurodegenerative diseases.

Metallomix Inc.

Panacea Venture is a healthcare venture fund with global vision and reach dedicated to transforming lives through promising innovation.

Panacea Venture

Protara Therapeutics is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. 

Website hero image for Cure resident Protara Therapeutics

Protara Therapeutics logo Cure Collaboration Residency

Protara Therapeutics

Sparian Biosciences is a clinical stage CNS-focused biopharmaceutical company committed to developing novel, transformational therapies. The company is set out to build a central nervous system-oriented company with innovative compounds that offer new approaches to address areas of high unmet medical need. Their initial focus is on pain and substance use disorders.

Patient Engagement Is the Secret to Smarter Research—Here’s How to Nail It

Meet the 15 Startups Joining Cure’s Middle East Health Accelerator

Your Home in NYC

Featured Event

X Factor: Healthcare Innovation Summit

Accelerating Advances in Health

Be part of Cure

Spotlight

Join the Cure Community

Explore Cure’s Collaboration Residency

Cure's C.ollaboration Residents

Get Smarter. Succeed Faster.

Be part of the Cure

Space availability

Join the Cure Ecosystem